Concerning Pathophysiology and Justifying Clinical Trials.
作者信息
Shamy Michel, Dewar Brian
机构信息
Ottawa Hospital & Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
出版信息
Am J Med. 2021 Jul;134(7):e439. doi: 10.1016/j.amjmed.2021.02.022.
Abstract
摘要
相似文献
1
Concerning Pathophysiology and Justifying Clinical Trials.关于病理生理学及临床试验的合理性
Am J Med. 2021 Jul;134(7):e439. doi: 10.1016/j.amjmed.2021.02.022.
2
Individual and societal risk factors of attitudes justifying intimate partner violence against women: a multilevel cross-sectional study.为亲密伴侣对女性实施暴力行为辩解的态度的个体和社会风险因素：一项多层次横断面研究。
BMJ Open. 2020 Dec 10;10(12):e037993. doi: 10.1136/bmjopen-2020-037993.
3
System-justifying beliefs and psychological well-being: the roles of group status and identity.系统正当化信念与心理健康：群体地位和身份的作用。
Pers Soc Psychol Bull. 2005 Dec;31(12):1718-29. doi: 10.1177/0146167205278261.
4
System-justifying ideologies and academic outcomes among first-year Latino college students.拉美裔大一学生的正当化意识形态与学术成果。
Cultur Divers Ethnic Minor Psychol. 2011 Oct;17(4):406-14. doi: 10.1037/a0025436.
5
Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice.血浆置换与血栓性微血管病：从病理生理学到临床实践。
Transfus Apher Sci. 2020 Dec;59(6):102990. doi: 10.1016/j.transci.2020.102990. Epub 2020 Nov 19.
6
Justifying placebo use in clinical trials.论证安慰剂在临床试验中的使用合理性。
J Tissue Viability. 2004 Jan;14(1):33. doi: 10.1016/s0965-206x(04)41007-9.
7
International ethical regulations on placebo-use in clinical trials: a comparative analysis.临床试验中使用安慰剂的国际伦理规范：一项比较分析。
Bioethics. 2008 Jan;22(1):64-74. doi: 10.1111/j.1467-8519.2007.00587.x.
8
[Justifying expedience connected with development of Federal Law "On chemical safety"].[为与《化学安全法》的制定相关的便利性提供正当理由]
Med Tr Prom Ekol. 2014(9):15-20.
9
Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN).由葡萄牙临床研究基础设施网络（PtCRIN）开展的研究者发起的临床试验。
Contemp Clin Trials Commun. 2016 Aug 20;4:141-148. doi: 10.1016/j.conctc.2016.08.002. eCollection 2016 Dec 15.
10
Justifying the choice of endpoints for clinical trials.为临床试验的终点选择提供依据。
J Natl Cancer Inst. 2013 Nov 6;105(21):1594-5. doi: 10.1093/jnci/djt289. Epub 2013 Oct 9.
引用本文的文献
1
Many trials of hydroxychloroquine for SARS-CoV-2 were redundant and potentially unethical: an analysis of the NIH clinical trials registry.许多针对 SARS-CoV-2 的羟氯喹试验是多余的，并且可能不道德：对 NIH 临床试验注册库的分析。
J Clin Epidemiol. 2022 Mar;143:73-80. doi: 10.1016/j.jclinepi.2021.11.011. Epub 2021 Nov 13.
本文引用的文献
1
A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment.一项关于氯喹和羟氯喹作为单一疗法或联合阿奇霉素治疗 COVID-19 的系统评价和荟萃分析。
Sci Rep. 2020 Dec 17;10(1):22139. doi: 10.1038/s41598-020-77748-x.
2
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
3
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.SARS-CoV-2（COVID-19）感染早期门诊治疗的病理生理基础和原理。
Am J Med. 2021 Jan;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003. Epub 2020 Aug 7.
4
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.羟氯喹或联合阿奇霉素治疗轻中度 COVID-19。
N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23.
5
Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial.羟氯喹治疗轻症 2019 年冠状病毒病成人患者的随机对照临床试验。
Clin Infect Dis. 2021 Dec 6;73(11):e4073-e4081. doi: 10.1093/cid/ciaa1009.
6
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.羟氯喹治疗非住院的 COVID-19 轻症成年患者：一项随机试验。
Ann Intern Med. 2020 Oct 20;173(8):623-631. doi: 10.7326/M20-4207. Epub 2020 Jul 16.
7
The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.羟氯喹与 COVID-19 ：一个警示故事。
Ann Intern Med. 2020 Oct 20;173(8):662-663. doi: 10.7326/M20-5041. Epub 2020 Jul 16.
8
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
9
Mild or Moderate Covid-19.轻度或中度新冠病毒感染
N Engl J Med. 2020 Oct 29;383(18):1757-1766. doi: 10.1056/NEJMcp2009249. Epub 2020 Apr 24.
Zotero 插件